Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell 4Lymphoma, Large-Cell, Anaplastic 2Immunoblastic Lymphadenopathy 2Subcutaneous panniculitis-like T-cell lymphoma 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Follicular 1Enteropathy-Associated T-Cell Lymphoma 1

Interventions

Specimen Handling 4Cyclophosphamide 4Biopsy 4Radiotherapy 3Nivolumab 3Magnetic Resonance Spectroscopy 3sodium-iodide symporter 2pembrolizumab 2mogamulizumab 2fludarabine phosphate 2fludarabine 2cemiplimab 2X-Rays 2Whole-Body Irradiation 2Tacrolimus 2Photons 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Immunoglobulin G 2Disulfides 2Busulfan 2Brentuximab Vedotin 2talimogene laherparepvec 1ruxolitinib 1hypericin 1duvelisib 1Vorinostat 1Transplantation 1Sirolimus 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × 10-propargyl-10-deazaaminopterin × 90 days × Clear all
NCT03598998 2026-05-26

Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas

City of Hope Medical Center

Phase 1/2 Active not recruiting
13 enrolled 12 charts
DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Follicular, Mycosis Fungoides, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡